I
Iason Psilopatis
Publications - 18
Citations - 42
Iason Psilopatis is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 18 publications receiving 42 citations.
Papers
More filters
Journal ArticleDOI
The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
Iason Psilopatis,Alexandros Pergaris,Kleio Vrettou,Gerasimos Tsourouflis,Stamatios Theocharis +4 more
TL;DR: The EPH/ephrin system represents a large family of biomolecules with promising applications in the fields of diagnosis, prognosis, disease monitoring, and treatment of gynecological cancer, with an established important clinical impact.
Journal ArticleDOI
The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
TL;DR: In this paper , the role of peroxisome proliferator-activated receptors (PPARs) in the pathophysiology of preeclampsia was investigated using the MEDLINE and LIVIVO databases.
Journal ArticleDOI
Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations
TL;DR: Interestingly, Histone Deacetylase Inhibitors have shown potent antitumor effects in clinical trials, thus possibly representing effective epigenetic therapeutic agents in TENs.
Journal ArticleDOI
Organoids: A New Chapter in Sarcoma Diagnosis and Treatment
Iason Psilopatis,Stefania Kokkali,K. Palamaris,Antonia Digklia,Kleio Vrettou,Stamatios Theocharis +5 more
TL;DR: The current manuscript represents the first comprehensive review of the literature focusing on the use of organoids for disease modelling and drug sensitivity testing in diverse sarcoma subtypes.
Journal ArticleDOI
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
Nikolaos Garmpis,Christos Damaskos,Dimitrios Dimitroulis,Gregory Kouraklis,Anna Garmpi,Panagiotis Sarantis,Evangelos Koustas,Alexandros Patsouras,Iason Psilopatis,Efstathios Antoniou,Michail Karamouzis,Konstantinos Kontzoglou,Afroditi Nonni +12 more
TL;DR: Higher HDAC-2 expression was related to lobular histological type of cancer, grade III, and stage III BC, and other factors correlating with worse survival were histological types other than ductal or lobular, and the stage of the disease.